Top Markets
#1 Black Phoenix Black Phoenix +166.46%
#2 Islamic Coin Islamic Coin +158.08%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +33.13%
#5 Cryptopia Cryptopia +21.67%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.53%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +18.20%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +16.14%
#9 Test Test +15.10%
#10 Useless Coin Useless Coin +8.91%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Igene Biotechnology, Inc. Igene Biotechnology, Inc.

Igene Biotechnology, Inc.

IGNE
Rank in Stocks #41580
Igene Biotechnology, Inc. is dedicated to the discovery, development,... Igene Biotechnology, Inc. is dedicated to the discovery, development, production, and commercialization of specialized ingredients for both human and animal nutrition. A key offering from the company is natural astaxanthin, a valuable nutrient utilized as a coloring agent for farmed salmon and trout. Additionally, it supplies a variety of ingredients and finished products to the nutraceutical and animal feed sectors. The company also extends its expertise through research and development services, which include enhancing microbial strains and skillfully developing and scaling up fermentation processes – from initial lab-based shake flasks to pilot plants and ultimately, commercial-sized fermentors. Furthermore, Igene provides analytical chemistry services for accurately identifying and quantifying carotenoids in food, feed, and animal tissues, notably offering verification to distinguish between wild and farm-raised salmonids. Established in 1981 and based in Columbia, Maryland, the company was originally named IGI Biotechnology, Inc. before officially adopting the name IGENE Biotechnology, Inc. in April 1986.
Share Price
$0.00001
Last synced: 2026-08-11
Market Cap
$15.65K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Igene Biotechnology, Inc. (IGNE)

Category

Basic Materials
P/E ratio for Igene Biotechnology, Inc. (IGNE)
P/E ratio as of 2026 TTM: 0
According to Igene Biotechnology, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Igene Biotechnology, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Corteva, Inc. Corteva, Inc.
Corteva, Inc.
CTVA.US
 52.13 -
US
Nutrien Ltd. Nutrien Ltd.
Nutrien Ltd.
NTR.TO
 - -
CA
Qinghai Salt Lake Industry Co.,Ltd Qinghai Salt Lake Industry Co.,Ltd
Qinghai Salt Lake Industry Co.,Ltd
000792.SZ
 - -
CN
CF Industries Holdings, Inc. CF Industries Holdings, Inc.
CF Industries Holdings, Inc.
CF.US
 - -
US
Zangge Mining Company Limited Zangge Mining Company Limited
Zangge Mining Company Limited
000408.SZ
 27.05 -
CN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.